StockNews.com Initiates Coverage on Can-Fite BioPharma (NYSE:CANF)
StockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a research report released on Sunday morning. The brokerage issued a hold rating on the stock. A number of other brokerages have also issued reports on CANF. HC Wainwright decreased their price target on Can-Fite BioPharma from $34.00 to $18.00 and set […]
More Stories
Nebius Group (NASDAQ:NBIS) Given New $80.00 Price Target at BWS Financial
Nebius Group (NASDAQ:NBIS – Free Report) had its price objective hoisted by BWS Financial from $60.00 to $80.00 in a...
Best Buy (NYSE:BBY) Given Buy Rating at Guggenheim
Guggenheim reaffirmed their buy rating on shares of Best Buy (NYSE:BBY – Free Report) in a research report sent to...
Citigroup (NYSE:C) Price Target Raised to $85.00 at The Goldman Sachs Group
Citigroup (NYSE:C – Free Report) had its price objective lifted by The Goldman Sachs Group from $75.00 to $85.00 in...
Cantor Fitzgerald Reiterates “Overweight” Rating for Varonis Systems (NASDAQ:VRNS)
Cantor Fitzgerald reissued their overweight rating on shares of Varonis Systems (NASDAQ:VRNS – Free Report) in a research note issued...
Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Crane (NYSE:CR) Stock Price
Crane (NYSE:CR – Free Report) had its price objective increased by Deutsche Bank Aktiengesellschaft from $187.00 to $226.00 in a...
PENN Entertainment (NASDAQ:PENN) Given Positive Rating at Susquehanna
Susquehanna reissued their positive rating on shares of PENN Entertainment (NASDAQ:PENN – Free Report) in a research note released on...